This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

RXC004

Redx Pharma Plc

Drug Names(s): RXC 004, RXC-004, Porcupine Inhibitor

Description: RXC004 is a novel small molecule inhibitor of the Porcupine (Porc) protein in the Wnt pathway. Wnt signalling is implicated in the maintenance of cancer stem cells. It will have the potential to be taken orally by patients as a once daily dose.


RXC004 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug